Lifestyle Interventions While medication is a powerful tool, sustainable habits remain the foundation of health
In the STEP 1 to STEP 4 studies, 1% to 2% of semaglutide patients reduced their dose of lipid-lowering medication versus 0 to 1% with placebo, and 1% to 4% of patients in the semaglutide group had a dose increase versus 2% to 5% of placebo patients
Compounded medications from Affinity Whole Health are prepared in FDA-registered compounding facilities and are not FDA-approved drugs
doi: 10.2991/jegh.k.191028.001 32 DelaneyKZSantosaS
Regular urine tests and close monitoring by a healthcare provider are essential to ensure the safety and effectiveness of the treatment
Vilsboll T, Bain SC, Leiter LA, Lingvay I, Matthews D, Simo R, et al